Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cyclopentane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloheptane SCHEMBL4093676 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL11040391 | 1.00 | FFAR3 (0.70) | — | |
| Acetic Acid SCHEMBL1396702 | 1.00 | — | — | |
| Cycloheptane SCHEMBL2012782 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL175231 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL2060004 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL6561216 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL7737259 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL482428 | 1.00 | FFAR3 (0.70) | — | |
| Cyclohexane SCHEMBL2060015 | 1.00 | FFAR3 (0.70) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111085269-B | Hydrogenation catalyst for preparing cyclopentene by cyclopentadiene hydrogenation, preparation method and hydrogenation method thereof | 中国石油化工股份有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-111087495-B | Hydrogenation catalyst for producing hydrogenated styrene-conjugated diene copolymer, method for producing hydrogenation catalyst, hydrogenation method, and hydrogenated copolymer | 中国石油化工股份有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-111085273-B | Hydrogenation catalyst for preparing cyclopentene by cyclopentadiene hydrogenation, preparation method and hydrogenation method thereof | 中国石油化工股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| WO-2022269335-A1 | A PROCESS FOR PREPARATION OF ALICYCLIC ACID DIANHYDRIDE | VIVAN LIFE SCIENCES PVT. LIMITED (IN) | 2022-12-29 | — | — | WO | claimed |
| CN-103874675-A | Process for the preparation of methoxymelonal | GIVAUDAN SA | 2014-06-18 | — | — | CN | claimed |
| JP-2000506513-A | — | — | 2000-05-30 | — | — | JP | claimed |
| US-6008398-A | Non-nucleotide phosphorus ester oligomers | GENZYME CORPORATION (US) | 1999-12-28 | — | — | US | claimed |
| EP-0880532-A4 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1999-06-09 | — | — | EP | claimed |
| EP-0880532-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1998-12-02 | — | — | EP | claimed |
| EP-0640142-B1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0804443-A4 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1998-04-29 | — | — | EP | claimed |
| EP-0804443-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1997028168-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-08-07 | — | — | WO | claimed |
| WO-1996022297-A9 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | — | 1996-10-03 | — | — | WO | claimed |
| WO-1996022297-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1996-07-25 | — | — | WO | claimed |
| EP-0640142-A1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER INC. (US) | 1995-03-01 | — | — | EP | claimed |
| WO-1993019194-A1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER INC. (US) | 1993-09-30 | — | — | WO | claimed |
| US-4282203-A | Hair lacquer and hair lotion compositions containing a copolymer having units of a vinyl allyl or methally ester of an α- or β-cyclic carboxylic acid | L'OREAL (FR) | 1981-08-04 | — | — | US | claimed |
| US-4272511-A | POLYMER OF VINYLPYRROLIDONE, VINYL ACETATE, CROTONIC ACID AND AT LEAST ONE OTHER MONOMER | L'OREAL (FR) | 1981-06-09 | — | — | US | claimed |
| US-20260000781-A1 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS INC (US) | 2026-01-01 | — | — | US | disclosed |
| CN-120077502-A | Electrolyte, electrochemical device, secondary battery, and lithium ion secondary battery | 大金工业株式会社 | 2025-05-30 | — | — | CN | disclosed |
| EP-4551563-A2 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS, INC. (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025064869-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | CIDARA THERAPEUTICS, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| CN-119497914-A | Negative electrode, battery, and method for coating battery material | 大金工业株式会社 | 2025-02-21 | — | — | CN | disclosed |
| CN-119487661-A | Secondary battery | 大金工业株式会社 | 2025-02-18 | — | — | CN | disclosed |
| CN-119422259-A | Surface treatment agent for electrode material, positive electrode active material, current collecting foil, negative electrode active material, conductive auxiliary agent, electrode, battery, method for producing positive electrode active material, method for producing current collecting foil, method for producing negative electrode active material, method for producing conductive auxiliary agent, and method for producing electrode | 大金工业株式会社 | 2025-02-11 | — | — | CN | disclosed |
| CN-119340488-A | Electrolyte, electrochemical device, lithium ion secondary battery and assembly | 大金工业株式会社 | 2025-01-21 | — | — | CN | disclosed |
| CN-119318048-A | Electrolyte and secondary battery using the same | 大金工业株式会社 | 2025-01-14 | — | — | CN | disclosed |
| CN-118786542-A | Electrode active material, electrode, electrochemical device, assembly and method | 国立大学法人京都大学 | 2024-10-15 | — | — | CN | disclosed |
| WO-2024010810-A2 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| CN-116848080-A | Compound, composition, electrochemical device, lithium ion secondary battery, and assembly | 大金工业株式会社 | 2023-10-03 | — | — | CN | disclosed |
| WO-2022269335-A1 | A PROCESS FOR PREPARATION OF ALICYCLIC ACID DIANHYDRIDE | VIVAN LIFE SCIENCES PVT. LIMITED (IN) | 2022-12-29 | — | — | WO | disclosed |
| US-11530176-B2 | Processes for preparing a 2-(1,2,2-trimethyl-3-cyclopentenyl)-2-oxoethyl carboxylate compound and hydroxymethyl 1,2,2-trimethyl-3-cyclopentenyl ketone, and a halomethyl (1,2,2-trimethyl-3-cyclopentenyl) ketone compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| EP-3808727-B1 | PROCESSES FOR PREPARING A 2-(1,2,2-TRIMETHYL-3-CYCLOPENTENYL)-2-OXOETHYL CARBOXYLATE COMPOUND AND HYDROXYMETHYL 1,2,2-TRIMETHYL-3-CYCLOPENTENYL KETONE, AND A HALOMETHYL (1,2,2-TRIMETHYL-3-CYCLOPENTENYL) KETONE COMPOUND | SHINETSU CHEMICAL CO (JP) | 2022-11-30 | — | — | EP | disclosed |
| US-20210114960-A1 | PROCESSES FOR PREPARING A 2-(1,2,2-TRIMETHYL-3-CYCLOPENTENYL)-2-OXOETHYL CARBOXYLATE COMPOUND AND HYDROXYMETHYL 1,2,2-TRIMETHYL-3-CYCLOPENTENYL KETONE, AND A HALOMETHYL (1,2,2-TRIMETHYL-3-CYCLOPENTENYL) KETONE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-22 | — | — | US | disclosed |
| EP-3808727-A1 | PROCESSES FOR PREPARING A 2-(1,2,2-TRIMETHYL-3-CYCLOPENTENYL)-2-OXOETHYL CARBOXYLATE COMPOUND AND HYDROXYMETHYL 1,2,2-TRIMETHYL-3-CYCLOPENTENYL KETONE, AND A HALOMETHYL (1,2,2-TRIMETHYL-3-CYCLOPENTENYL) KETONE COMPOUND | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-04-21 | — | — | EP | disclosed |
| EP-2499225-B1 | CLEANING METHOD | PROCTER & GAMBLE (US) | 2017-06-28 | — | — | EP | disclosed |
| CN-105596233-A | Anhydrous fluid filtering composition comprising an oily phase, a particular triazine filter and an oil thickening or gelling rheological agent | OREAL | 2016-05-25 | — | — | CN | disclosed |
| CN-104204198-A | Lipase variants and polynucleotides encoding same | NOVOZYMES AS | 2014-12-10 | — | — | CN | disclosed |
| WO-2014141035-A2 | FUSED HETEROCYCLYL DERIVATIVES AS NAMPT INHIBITORS | AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) | 2014-09-18 | — | — | WO | disclosed |
| CN-103874675-A | Process for the preparation of methoxymelonal | GIVAUDAN SA | 2014-06-18 | — | — | CN | disclosed |
| US-8449626-B2 | Cleaning method | THE PROCTER & GAMBLE COMPANY (US) | 2013-05-28 | — | — | US | disclosed |
| CN-103087221-A | Polymer hydrogenation method | CHINA PETROLEUM & CHEMICAL | 2013-05-08 | — | — | CN | disclosed |
| US-8420772-B2 | Semi-aromatic polyamide and a method for preparation with low wastewater discharge | Kingfa Science & Technology Co., Ltd (CN) | 2013-04-16 | — | — | US | disclosed |
| CN-102977230-A | Method for removing hydrogenation catalyst in polymer solution | CHINA PETROLEUM & CHEMICAL | 2013-03-20 | — | — | CN | disclosed |
| EP-2499225-A1 | CLEANING METHOD | The Procter & Gamble Company (US) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011060109-A1 | CLEANING METHOD | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110107527-A1 | CLEANING METHOD | THE PROCTER & GAMBLE COMPANY | 2011-05-12 | — | — | US | disclosed |
| EP-2301985-A1 | A SEMI-AROMATIC POLYAMIDE AND THE PROCESS WITH LOW AMOUNT OF WASTE WATER DISCHARGE FOR PREPARING THE SAME | Kingfa Science & Technology Co., Ltd. (CN) | 2011-03-30 | — | — | EP | disclosed |
| US-20100267923-A1 | SEMI-AROMATIC POLYAMIDE AND A METHOD FOR PREPARATION WITH LOW WASTEWATER DISCHARGE | KINGFA SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2010-10-21 | — | — | US | disclosed |
| EP-2166018-A2 | Antibody binding affinity ligands | Novo Nordisk A/S (DK) | 2010-03-24 | — | — | EP | disclosed |
| EP-1831243-B1 | ANTIBODY BINDING AFFINITY LIGANDS | NOVO NORDISK AS (DK) | 2010-03-17 | — | — | EP | disclosed |
| US-20080311681-A1 | Antibody Binding Affinity Ligands | VERSAMATRIX A/S (DK) | 2008-12-18 | — | — | US | disclosed |
| EP-1961725-A1 | Odorous and aroma substances, their manufacture and utilisation | Symrise GmbH & Co. KG (DE) | 2008-08-27 | — | — | EP | disclosed |
| US-7387991-B2 | Microemulsions containing alkoxylated amine carboxylates | HUDSON ALICE P | 2008-06-17 | — | — | US | disclosed |
| CN-100390541-C | Methods for optimal usage and improved valuation of corrosive petroleum feedstocks and fractions | EXXONMOBIL RES & ENG CO (US) | 2008-05-28 | — | — | CN | disclosed |
| EP-1831243-A2 | ANTIBODY BINDING AFFINITY LIGANDS | Novo Nordisk A/S (DK) | 2007-09-12 | — | — | EP | disclosed |
| US-20070082834-A1 | Microemulsions containing alkoxylated amine carboxylates | HUDSON ALICE P | 2007-04-12 | — | — | US | disclosed |
| US-7091211-B2 | Cyclopentyl modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2006-08-15 | — | — | US | disclosed |
| WO-2006066598-A2 | ANTIBODY BINDING AFFINITY LIGANDS | NOVO NORDISK A/S (DK) | 2006-06-29 | — | — | WO | disclosed |
| CN-1724597-A | Phase change inks | XEROX CORP (US) | 2006-01-25 | — | — | CN | disclosed |
| EP-1225895-B1 | FAB I INHIBITORS | AFFINIUM PHARM INC (CA) | 2005-05-04 | — | — | EP | disclosed |
| US-20050070609-A1 | Cyclopentyl modulators of chemokine receptor activity | MERCK SHARP & DOHME CORP. | 2005-03-31 | — | — | US | disclosed |
| US-6762201-B1 | SUCH AS N-((2-AMINO-5-(N-METHYL-N-((1-METHYLINDOL-2-YL) -METHYL)CARBAMOYL)PHENYL)METHYL)-N-METHYLACETAMIDE; BACTERIAL INFECTIONS | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2004-07-13 | — | — | US | disclosed |
| EP-0766674-B1 | NEW HIV PROTEASE INHIBITORS | MERCK & CO INC (US) | 2003-10-15 | — | — | EP | disclosed |
| US-6599472-B1 | Zinc carboxylates or zinc hydroxy carboxylates | SURFACE CHEMISTS OF FLORIDA INC. | 2003-07-29 | — | — | US | disclosed |
| US-6506777-B1 | Method for modulation of CCR-3 or CCR-5 chemokine receptor activity in a mammal in need thereof to treat asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis, which comprises the administration of an | MERCK & CO., INC. | 2003-01-14 | — | — | US | disclosed |
| EP-1225895-A4 | FAB I INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6432981-B1 | BLOCKS HUMAN IMMUNODEFICIENCY VIRUS (HIV) FROM ENTERING CELLS; AUTOIMMUNE DISEASES; ANTIALLERGENS, ANTIINFLAMMATORY AND ANTIASTHMATIC AGENTS | MERCK & CO., INC. | 2002-08-13 | — | — | US | disclosed |
| EP-1225895-A1 | FAB I INHIBITORS | SmithKline Beecham Corporation (US) | 2002-07-31 | — | — | EP | disclosed |
| CN-1344368-A | Methods for optimal usage and improved valuation of corrosive petroleum feedstocks and fractions | EXXONMOBIL RES & ENG CO (US) | 2002-04-10 | — | — | CN | disclosed |
| US-6362168-B1 | Antiparasitic agents | PFIZER INC. | 2002-03-26 | — | — | US | disclosed |
| CN-1314906-A | Salts of paroxetine | SMITHKLINE BEECHAM PLC (GB) | 2001-09-26 | — | — | CN | disclosed |
| WO-2001026654-A1 | FAB I INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-04-19 | — | — | WO | disclosed |
| WO-2000076513-A1 | CYCLOPENTYL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000076514-A1 | CYCLOPENTYL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| US-6103504-A | STREPTOMYCES MUTANT LACKING BRANCHED-CHAIN AMINO ACID TRANSAMINASE ACTIVITY, BRANCHED-CHAIN OXO ACID BIOSYNTHETIC ACTIVITY AND LACKING AVERMECTIN B-O-METHYL TRANSFERASE ACTIVITY; FOR PRODUCTION OF PARASITIDES AND ANTHELMINTICS | PFIZER INC. (US) | 2000-08-15 | — | — | US | disclosed |
| US-6008398-A | Non-nucleotide phosphorus ester oligomers | GENZYME CORPORATION (US) | 1999-12-28 | — | — | US | disclosed |
| US-5919965-A | Non-nucleotide phosphorus ester oligomers | GENZYME CORPORATION (US) | 1999-07-06 | — | — | US | disclosed |
| EP-0880532-A4 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0880532-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| US-5804078-A | Method of removing water soluble organics from oil process water | TEXACO INC. (US) | 1998-09-08 | — | — | US | disclosed |
| EP-0640142-B1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER (US) | 1998-05-20 | — | — | EP | disclosed |
| EP-0804443-A4 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1998-04-29 | — | — | EP | disclosed |
| US-5702924-A | Process for preparing antiparasitic agents | PFIZER INC. (US) | 1997-12-30 | — | — | US | disclosed |
| EP-0804443-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| EP-0766674-A4 | NEW HIV PROTEASE INHIBITORS | MERCK & CO INC (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997028168-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-08-07 | — | — | WO | disclosed |
| EP-0766674-A1 | NEW HIV PROTEASE INHIBITORS | MERCK & CO. INC. (US) | 1997-04-09 | — | — | EP | disclosed |
| WO-1996022297-A9 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | — | 1996-10-03 | — | — | WO | disclosed |
| WO-1996022297-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1996-07-25 | — | — | WO | disclosed |
| WO-1995035286-A1 | NEW HIV PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 1995-12-28 | — | — | WO | disclosed |
| US-5476874-A | Oligopeptide analogs containing sulfonamide, urea, carbamate, | MERCK & CO., INC. (US) | 1995-12-19 | — | — | US | disclosed |
| CN-1096299-A | Antiherpes peptide derivatives with ureido N-terminus | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1994-12-14 | — | — | CN | disclosed |
| WO-1994003483-A1 | ENDOTHELIN RECEPTOR-BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0317148-B1 | ANTIPARASITIC AGENTS | Pfizer Limited (GB) | 1993-02-17 | — | — | EP | disclosed |
| EP-0417760-A2 | Phenylalkanoyl substituted imidazo[4,5-c] pyridines | G.D. Searle & Co. (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4988707-A | Platelet activating factor, antiinflammatory agents, cardiovascular disorders and treatment of asthma | G. D. SEARLE & CO. (US) | 1991-01-29 | — | — | US | disclosed |
| EP-0317148-A2 | Antiparasitic agents | Pfizer Limited (GB) | 1989-05-24 | — | — | EP | disclosed |
| EP-0237189-A2 | Therapeutic and related uses of dithiol peptides | REPLIGEN CORPORATION (US) | 1987-09-16 | — | — | EP | disclosed |
| US-4401817-A | ANTIVIRAL AGENTS | ELI LILLY AND COMPANY (US) | 1983-08-30 | — | — | US | disclosed |
| US-4338329-A | COMBATTING RHINOVIRUSES | ELI LILLY AND COMPANY (US) | 1982-07-06 | — | — | US | disclosed |
| US-4289782-A | PARTICULARLY FOR INHIBITING GROWTH OF RHINOVIRUSES | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| US-4233454-A | Cyclopentane acetic acid derivatives | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-11-11 | — | — | US | disclosed |
| US-4230868-A | α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles | ELI LILLY AND COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
| US-4174454-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1979-11-13 | — | — | US | disclosed |
| US-4118742-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4026720-A | HYDROLYZED SILOXANE, ALKALI METAL-ZINC SALTS OF NAPHTHENIC ACID, ACETIC ACID | DAICEL, LTD. (JA) | 1977-05-31 | — | — | US | disclosed |
| US-4026720-A | HYDROLYZED SILOXANE, ALKALI METAL-ZINC SALTS OF NAPHTHENIC ACID, ACETIC ACID | DAICEL, LTD. (JA) | 1977-05-31 | — | — | US | disclosed |